Sacituzumab govitecan
Definition: Sacituzumab govitecan, sold under the brand name Trodelvy by Gilead Sciences, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. The most common side effects include nausea, neutropenia, diarrhea, fatigue, anemia, vomiting, alopecia (hair loss), constipation, decreased appetite, rash and abdominal pain. Sacituzumab govitecan has a boxed warning about the risk of severe neutr... source: Wikipedia
- ID
- 871701001
- ID date
- 17 Jun 2022
- Previous ID
- 39769611000001108
- Name
- Sacituzumab govitecan